Status:
COMPLETED
Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins
Lead Sponsor:
Meir Medical Center
Conditions:
Venous Thrombosis
Pulmonary Embolism
Eligibility:
All Genders
18+ years
Brief Summary
Many drug interactions with Warfarin are well documented in the literature, including interactions with a variety of antibiotics. However,in mamy cases it is difficult to predict when the interaction ...
Eligibility Criteria
Inclusion
- Patients aged 18 and over
- Patients treated with a combination of Warfarin and Cephalosporins
- Patients who were hospitalized in the department of internal medicine
- Patients who were treated with Warfarin without Cefalosporins
Exclusion
- Patients on Warfarin who did not actually receive the drug during their hospitalization
- Patients whose medical records were not accessible or didn't contain full data
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
236 Patients enrolled
Trial Details
Trial ID
NCT01857050
Start Date
April 1 2013
End Date
January 1 2014
Last Update
February 25 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.